Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin prophylaxis in third molar surgery
NCT06613776Phase 4Completed
- Sponsor
- Universidad Católica San Antonio de Murcia
- Start
- Oct 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin in surgical site infection (SSI) (2 arms), sponsored by Universidad Católica San Antonio de Murcia. Primary endpoint: Pain reported by patients at 6 days. Started Oct 2023; status: completed.
02
Drugs
amoxicillin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06613776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06613776.